Techcyte, Inc.
PrivateLast Round
Early Funding
Apr 30, 2026
Total Funding Raised
$49.61M
Momentum Score
50 /100
Company Overview
Techcyte, Inc. is a healthtech company that provides an AI-powered digital pathology platform for anatomic and clinical pathology.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Techcyte, Inc. Comps
Public and private peers based on sector, stage, and business model.
Techcyte, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 30, 2026 | ||||
| VC Round | Jan 11, 2024 | ||||
| Series E | Aug 18, 2021 | ||||
| Seed | Jan 18, 2018 | ||||
| Series A | Jan 18, 2018 | ||||
Seed | Mar 1, 2016 |
Key People
Founding team and executive leadership
Techcyte, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mayo Clinic Ventures | Early Funding |
| Van Tuyl Companies | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
$15M raised, led by Van Tuyl Companies.
Techcyte, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Techcyte, Inc.'s valuation, stock price, and market status.
